Pro-Dex (PDEX) Expected to Announce Earnings on Thursday

Pro-Dex (NASDAQ:PDEX) will likely be announcing its Q3 2025 earnings results before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of $0.47 per share and revenue of $17.70 million for the quarter.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings results on Thursday, January 30th. The medical instruments supplier reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.23. Pro-Dex had a return on equity of 21.68% and a net margin of 11.06%. On average, analysts expect Pro-Dex to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Pro-Dex Stock Performance

Shares of PDEX opened at $69.00 on Tuesday. Pro-Dex has a 1 year low of $16.84 and a 1 year high of $70.26. The stock has a market capitalization of $225.01 million, a PE ratio of 34.33 and a beta of 0.40. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.44 and a current ratio of 2.58. The stock has a 50-day simple moving average of $49.90 and a 200-day simple moving average of $44.94.

Insider Activity at Pro-Dex

In related news, Director Raymond E. Cabillot sold 3,096 shares of the business’s stock in a transaction on Wednesday, March 26th. The shares were sold at an average price of $50.13, for a total value of $155,202.48. Following the completion of the sale, the director now directly owns 279,787 shares of the company’s stock, valued at $14,025,722.31. The trade was a 1.09 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders have sold 22,483 shares of company stock valued at $1,080,693 in the last ninety days. Insiders own 47.50% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com cut shares of Pro-Dex from a “buy” rating to a “hold” rating in a research report on Wednesday, March 12th.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.